Immuron Limited (IMRN)


Immuron Limited (IMRN)

$3.06 USD

0.10 (3.38%)

Updated Jun 19 12:26pm

Add IMRN to Watchlist
Sign Up

Overall POWR Rating

Sign Up for Ratings

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 207 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

IMRN Daily Price Range
IMRN 52-Week Price Range
Learn More About POWR Ratings

IMRN News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All IMRN News

Immuron Limited (IMRN) Company Bio

Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.

IMRN Stock Chart More Charts

IMRN Price/Volume Stats

Current price $3.06
Prev. close $2.96
Day low $2.90
Day high $3.40
50-day MA $4.65
200-day MA $7.27
52-week high $14.29
52-week low $2.38
Volume 18,606
Avg. volume 43,460
Dividend yield N/A
Market Cap 10.92M

IMRN Social Stream

Loading social stream, please wait...

View Full IMRN Social Stream

IMRN Returns

1-mo -42.05%
3-mo N/A
6-mo -44.16%
1-year -66.30%
3-year N/A
5-year N/A
YTD N/A
2018 0.00%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Top Stories View All

Pot stock CannTrust Holdings (CTST) announces entrance into U.S. market

Apple (AAPL) looks at moving iPhone production out of China

UBS predicts Disney's (DIS) streaming service will surpass expectations

Amazon (AMZN) is revamping it's streaming platform to take on Roku (ROKU) and Hulu

Canopy Growth's (CGC) earnings results on Thursday will be critical for the marijuana sector

View All Top Stories
Page generated in 0.4262 seconds.